Orthofix Medical Inc. Files Form 8-K Announcing Amendment to Stock Purchase Plan and Annual Meeting Results
Orthofix Medical Inc. Announces Shareholder Approval of Amen...
Sign in to continue:
Orthofix Medical Inc. Announces Shareholder Approval of Amen...
C4 Therapeutics, Inc. Announces New Data and Corporate Updat...
Nurix Therapeutics Releases Promising Updated Phase 1a/1b Da...
Biomea Fusion, Inc. Reports Results of 2026 Annual Meeting o...
Climb Bio, Inc. Announces Initial Data from Phase 1b Study o...
McGraw Hill, Inc. FY2026 Results: Key Highlights for Investo...
Xeris Biopharma Announces \$23 Million Convertible Note Exch...
Driven Brands Holdings Inc. Reports Q1 2026 Results: Key Hig...
Rigetti Computing, Inc. - 8-K Report Detailed Investor Summa...
Silence Therapeutics: EHA 2026 Divesiran Data Update – Detai...